New Method for Fabricating monodispersed Fe-oxide@au nanoparticles in the range of 5-100nm

Description:

Core-Shell Nanoparticles with Multiple Cores and a Method for Fabricating Them

 

Nanoparticles exhibit intriguing changes in electronic, optical, and magnetic properties as a result of the nanoscale dimensionality. The ability to engineer size, shape, composition, and structure is essential for the exploration of these properties. However, one of the major obstacles is the lack of flexibility in surface modification and biocompatibility.

 

This invention relates to a novel thermal approach to the fabrication of core-shell magnetic nanoparticles. It demonstrates a simple and effective approach based on thermally-activated hetero-interparticle coalescence between gold/silver and iron-oxide nanoparticles for the fabrication of monodispersed core-shell magnetic nanoparticles in the size range of 5-100 nm diameters. The iron oxide core (Fe2O3 or Fe3O4) is magnetically active while the gold or silver shell enables the flexibility in surface modification and biocompatibility. The cores can be single or multiple (“pomegranate”), depending on preparation conditions. The construct can thus be used to identify, purify, quantify and/or separate biological or synthetic target molecules using a magnetic field.

 

APPLICATIONS

 

Separation: bio-separation of proteins, DNA, and pollutants taking advantage of magnetic core

Drug Targeting/Delivery: target drug-carrying magnetic particles to a desired body site, for example in chemotherapy

Protein Binding: bio-assay exploiting the ability to bind proteins using the surface chemistry of the shell

Medical Imaging: contrast agent in medical imaging tests such as MRI, X-Ray, or micro CT

 

ADVANTAGES

 

Surface tunability for biocompatible applications using well-known gold surface chemistry and biological reactivity of gold allows use of particles of sufficient size (>15 nm) to exploit magnetic properties.

Replace toxic heavy metals such as Gadolinium or Iodine as a contrast agent.

Deliver concentrated chemotherapeutic drugs to specific tissue instead of throughout body, reducing side effects.

 

INVENTOR

 

Dr. C.J. Zhong is a Professor of Materials Chemistry, Analytical Chemistry, Catalysis, Electrochemistry, and Nanotechnology at the State University of New York (SUNY) at Binghamton. His research interests include focusing on the design, synthesis, characterization, and application of novel strategies and functional nanomaterials for solving challenging problems in sustainable energy production, conversion and storage (e.g., fuel cells and batteries), and in chemical, biological, and biomedical detection and intervention (e.g., chemical sensors and biosensors).

 

 

 

I.P.

 

U.S. Patent 8,343,627 & patent pending

 

CONTACT

 

Scott Moser, Esq.

Technology Licensing Assistant

smoser@binghamton.edu

Phone: (607) 777-2685

 

Patent Information:
For Information, Contact:
Scott Hancock
Director, IP Management and Licensing
Binghamton University
(607) 777-5874
shancock@binghamton.edu
Inventors:
Hye-Young Park
Chuan-Jian Zhong
Keywords:
© 2017. All Rights Reserved. Powered by Inteum